X-ZELL Blog Episode 16

Episode 16 Thriving in Adversity: how health tech start-ups are navigating Covid-19 It didn’t take long for the first wave of defeatism to hit the start-up community. On 1 April 2020, less than a month after Italy became the first country to impose a national lockdown...

X-ZELL closes oversubscribed Seed+ round

X-ZELL closes oversubscribed Seed+ round Singapore, October 2020 – Singapore start-up X-ZELL has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen (DIAG). Ranked among the world’s most innovative health...

Next generation Cryoimmunostaining™ Suite revealed

Next generation Cryoimmunostaining™ coming Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite, comprised of the Cryofixator™ and Cryostainer™, is about to receive a...

X-ZELL part of Galen Growth’s 2020 HealthTech Cohort

X-ZELL part of Galen Growth’s 2020 HealthTech Cohort Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across...